News

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...
Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...
Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...
A small case-control study found potential molecular evidence that links human papillomavirus (HPV) to thyroid eye disease ...
Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...
Abstracts are available on the EASL Congress 2025 website at https://www.easlcongress.eu/. The posters are expected to be ...
A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...
CNW/ -- (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to jointly announce ...
Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...
Nigel McCracken, chief operating officer, Virax Biolabs explains how the ViraxImmune PAIS assay uses T cell responses and cytokine levels to detect immune dysfunction and identify viral triggers of ...
Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...